Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) – Analysts at Leerink Partnrs upped their Q2 2024 earnings estimates for Compass Therapeutics in a research report issued on Monday, May 13th. Leerink Partnrs analyst A. Berens now anticipates that the company will post earnings of ($0.11) per share for the quarter, up from their prior estimate […]
Compass Therapeutics (CMPX) Outperform Rating Reaffirmed at Wedbush themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Foresite Capital Management V LLC cut its holdings in Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) by 5.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,246,977 shares of the company’s stock after selling 77,094 shares during the period. Compass Therapeutics […]
Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Free Report) saw a significant drop in short interest in January. As of January 15th, there was short interest totalling 1,980,000 shares, a drop of 12.8% from the December 31st total of 2,270,000 shares. Based on an average trading volume of 511,500 shares, the short-interest ratio is currently 3.9 […]
Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Free Report) was the recipient of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 2,670,000 shares, a decline of 10.1% from the November 15th total of 2,970,000 shares. Based on an average trading volume of 312,500 shares, […]